Study to Investigate the Safety, Pharmacokinetics, Pharmacodynamics and Preliminary Clinical Activity of Defactinib in Combination With Avelumab in Epithelial Ovarian Cancer
|
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. |
| ClinicalTrials.gov Identifier: NCT02943317 |
|
Recruitment Status :
Terminated
(The study was terminated upon completion of escalation phase, prior to opening expansion cohorts)
First Posted : October 24, 2016
Last Update Posted : April 30, 2019
|
Sponsor:
Verastem, Inc.
Information provided by (Responsible Party):
Verastem, Inc.
- Study Details
- Tabular View
- No Results Posted
- Disclaimer
- How to Read a Study Record
No Study Results Posted on ClinicalTrials.gov for this Study
| Recruitment Status : | Terminated |
|---|---|
| Actual Primary Completion Date : | August 28, 2018 |
| Actual Study Completion Date : | December 28, 2018 |